Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro

Cited by papers we hold 6

• Signaling pathways in rheumatoid arthritis: implications for targeted therapy · 2023
  No notice
• Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies · 2021
  No notice
• Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites · 2021
  No notice
• Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer · 2021
  No notice
• Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis · 2021
  No notice
• IDO and Kynurenine Metabolites in Peripheral and CNS Disorders · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.